Rutabaga Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Rutabaga Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-19,432	Closed	-$1.66M	–	47
2019 Q3	$1.66M	Sell	19,432 -8,229	-30%	-$879K	0.59%	49
2019 Q2	$3.53M	Sell	27,661 -2,720	-9%	-$392K	1.01%	42
2019 Q1	$5.48M	Buy	30,381 +10,739	+55%	+$1.55M	1.51%	26
2018 Q4	$2.18M	Sell	19,642 -27,238	-58%	-$3.55M	0.72%	41
2018 Q3	$6.33M	Buy	46,880 +1,037	+2%	+$143K	1.45%	33
2018 Q2	$6.33M	Buy	45,843 +8,396	+22%	+$1.15M	1.37%	34
2018 Q1	$5.17M	Buy	37,447 +18,885	+102%	+$2.57M	1.22%	33
2017 Q4	$2.28M	Sell	18,562 -26,824	-59%	-$3.68M	0.53%	41
2017 Q3	$6.2M	Buy	45,386 +17,241	+61%	+$2.6M	1.32%	24
2017 Q2	$4.94M	Buy	+28,145	New	+$4M	0.92%	40

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HPM

HealthCor Partners Management Charleston, South Carolina $50.7M AUM

Rutabaga Capital Management's SRGA Position: Q4 2019 in Review

Rutabaga Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2019, closing a stake of 19,432 shares — an estimated $1.66M sold.

Rutabaga Capital Management first reported a position in SRGA in Q2 2017 and held it in 10 quarters. The position peaked at $6.33M in Q3 2018. 88 funds tracked by Wall St. Rank hold SRGA as of Q4 2019.

Rutabaga Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Rutabaga Capital Management sold 19,432 Surgalign Holdings, Inc. Common Stock shares in Q4 2019, an estimated $1.66M.
Rutabaga Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Rutabaga Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $6.33M in Q3 2018.
88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2019.

Based on Rutabaga Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.